[PDF][PDF] Guidelines on oral anticoagulation with warfarin

D Keeling, T Baglin, C Tait, H Watson, D Perry… - Br J …, 2011 - leukemia-cell.org
1.1 Žilní trombembolismus Cílová hodnota INR u první epizody žilního trombembolismu má
být 2, 5. V úvodu léčby se má současně s užíváním warfarinu zahájit také parenterální …

Atrial fibrillation and ischemic stroke: a clinical review

I Migdady, A Russman, AB Buletko - Seminars in Neurology, 2021 - thieme-connect.com
Atrial fibrillation (AF) is an important risk factor for ischemic stroke resulting in a fivefold
increased stroke risk and a twofold increased mortality. Our understanding of stroke …

Guidelines on the management of valvular heart disease (version 2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society …

Authors/Task Force Members, A Vahanian… - European heart …, 2012 - academic.oup.com
After publication, dissemination of the message is of paramount importance. Pocket-sized
versions and personal digital assistant (PDA) downloadable versions are useful at the point …

[图书][B] Goldman's cecil medicine E-book

L Goldman, AI Schafer - 2011 - books.google.com
Stay on the cutting edge with the newly revised eBook of Goldman's Cecil Medicine, with
over 400 updates personally selected by Dr. Lee Goldman and integrated directly into each …

Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association

TM Giglia, MP Massicotte, JS Tweddell, RJ Barst… - Circulation, 2013 - Am Heart Assoc
Thrombosis has long been recognized as a potentially lifethreatening complication in
children with congenital heart disease (CHD), children with acquired heart disease, and in …

Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European heart rhythm association (EHRA) and …

GYH Lip, JP Collet, R Caterina, L Fauchier… - Ep …, 2017 - academic.oup.com
Atrial fibrillation (AF) is a major worldwide public health problem, and AF in association with
valvular heart disease (VHD) is also common. However, management strategies for this …

Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial

M Özkan, S Gündüz, M Biteker, MA Astarcioglu… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives: The aim of this prospective study was to identify the most effective and safest
regimen among different thrombolytic treatment strategies. Background: The best treatment …

What is 'valvular'atrial fibrillation? A reappraisal

R De Caterina, AJ Camm - European heart journal, 2014 - academic.oup.com
Despite the same electrophysiological abnormality, the risk of stroke and systemic embolism
in atrial fibrillation (AF) ranges from, 1%/year to. 20%/year and can be assessed by simple …

Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends

JCJ Sun, MJ Davidson, A Lamy, JW Eikelboom - The Lancet, 2009 - thelancet.com
Over 4 million people worldwide have received a prosthetic heart valve, and an estimated
300 000 valves are being implanted every year. Prosthetic heart valves improve quality of …

Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding

C Mérie, L Køber, PS Olsen, C Andersson, G Gislason… - Jama, 2012 - jamanetwork.com
Context The need for anticoagulation after surgical aortic valve replacement (AVR) with
biological prostheses is not well examined. Objective To perform a nationwide study of the …